SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061516
Filing Date
2023-11-09
Accepted
2023-11-09 07:07:07
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amlx-20230930.htm   iXBRL 10-Q 3754021
2 EX-31.1 amlx-ex31_1.htm EX-31.1 18385
3 EX-31.2 amlx-ex31_2.htm EX-31.2 18377
4 EX-31.3 amlx-ex31_3.htm EX-31.3 18377
5 EX-32.1 amlx-ex32_1.htm EX-32.1 10045
6 EX-32.2 amlx-ex32_2.htm EX-32.2 10043
7 EX-32.3 amlx-ex32_3.htm EX-32.3 10042
  Complete submission text file 0000950170-23-061516.txt   11003451

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amlx-20230930_cal.xml EX-101.CAL 54555
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amlx-20230930.xsd EX-101.SCH 54532
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amlx-20230930_lab.xml EX-101.LAB 457325
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amlx-20230930_pre.xml EX-101.PRE 326363
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amlx-20230930_def.xml EX-101.DEF 159524
68 EXTRACTED XBRL INSTANCE DOCUMENT amlx-20230930_htm.xml XML 2007712
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41199 | Film No.: 231390018
SIC: 2834 Pharmaceutical Preparations